NDC 62175-272 – Oxybutynin Chloride Extended Release

Oxybutynin Chloride 15 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug 1 recall

Product NDC62175-272

Product details

Brand name
Oxybutynin Chloride Extended Release
Generic name
Oxybutynin Chloride
Labeler
Lannett Company, Inc.
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA078503
Marketed since
March 1, 2009
Listing expires
December 31, 2026
Pharmacologic class
Cholinergic Muscarinic Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Oxybutynin Chloride →

Package NDC codes (2)

Package NDCDescriptionSince
62175-272-37100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-272-37)Mar 1, 2009
62175-272-41500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-272-41)Mar 1, 2009

Recalls mentioning this NDC

Other Oxybutynin Chloride products